Magellan Biosciences subsidiary Dynex Technologies will introduce its new DS2 System, a fully automated clinical-diagnostic workstation, at the upcomiong Medica 2005 trade show in Dusseldorf, Germany.
The DS2 is the first of many new products in Magellan's pipeline that target the clinical-diagnostics market, said Magellan president and CEO, Robert Rosenthal. "Increasingly, physicians are looking to improve health outcomes by bringing diagnostic products closer to the patient so they can get more accurate, immediate results, and respond more quickly with appropriate treatments or therapies. The DS2 makes this possible," said Rosenthal.
"We believe that the DS2 fills a significant unmet need in the marketplace, serving the large number of clinical labs worldwide that would like to enhance their processes through automation, but have too small volume requirements to justify the investment in the systems currently on the market."